[测定血清抗凝血酶以确定急性心血管疾病中的血浆高凝状态。II. 抗凝血酶活性的正常数值以及抗凝剂和链激酶在人类及常用实验动物体内的作用] - Suppr | 超能文献

[Determination of serum antithrombins for the determination of plasmatic hypercoagulability in acute cardiovascular diseases. II. Normal values of antithrombin capacity and the in vivo effect of anticoagulants and streptokinase in humans and frequently used laboratory animals].

作者信息

Duck H J, Köhler H, Trenckmann H, Fiedler G

出版信息

Z Gesamte Inn Med. 1979 Mar 1;34(5):133-8.

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

[Determination of serum antithrombins for the determination of plasmatic hypercoagulability in acute cardiovascular diseases. II. Normal values of antithrombin capacity and the in vivo effect of anticoagulants and streptokinase in humans and frequently used laboratory animals].[测定血清抗凝血酶以确定急性心血管疾病中的血浆高凝状态。II. 抗凝血酶活性的正常数值以及抗凝剂和链激酶在人类及常用实验动物体内的作用]

Z Gesamte Inn Med. 1979 Mar 1;34(5):133-8.

2

[Determination of serum antithrombin for the detection of plasmatic hypercoagulability in acute cardiac-circulatory diseases. I. Enzymatic method for the determination of serum anti-thrombins].

Z Gesamte Inn Med. 1978 Apr 15;33(8):242-7.

3

[Changes in antithrombin III during treatment with heparin].[肝素治疗期间抗凝血酶III的变化]

Nouv Presse Med. 1978 Jan 14;7(2):120.

4

[Studies on plasma hypercoagulability. 1. Heparin resistance in various diseases and its relation to coagulation factors, anticoagulant therapy, platelet and heparin co-factor].[血浆高凝性研究。1. 各种疾病中的肝素抵抗及其与凝血因子、抗凝治疗、血小板和肝素辅因子的关系]

Naika Hokan. 1969 Apr;16(4):127-38.

5

[Blood coagulation studies during streptokinase, heparin and plasmin therapy].

Z Gesamte Inn Med. 1968 Mar 1;23(5):Suppl:80 c.

6

Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations.遗传性抗凝血酶缺乏患者使用抗凝血酶α：在高风险情况下预防性静脉给药的3期研究。

Thromb Haemost. 2008 Mar;99(3):616-22. doi: 10.1160/TH07-08-0489.

7

An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.一种藻类硫酸化半乳聚糖对静脉血栓形成具有不同寻常的双重作用，这是由于它激活了因子XII并抑制了凝血蛋白酶。

Thromb Haemost. 2008 Mar;99(3):531-8. doi: 10.1160/TH07-10-0649.

8

[Inhibition of plasmatic coagulation: what is new?].[血浆凝固的抑制作用：有哪些新进展？]

Hamostaseologie. 2006 May;26(2):154-7.

9

Further investigations on antithrombin III in the plasmas of patients with the abnormality of antithrombin III Budapest.关于布达佩斯抗凝血酶III异常患者血浆中抗凝血酶III的进一步研究。

Thromb Diath Haemorrh. 1975 Jun 30;33(3):564-72.

10

Small doses of heparin and a new concept of hypercoagulability.

Thromb Diath Haemorrh. 1975 Feb 28;33(1):81-6.